salicylic acid has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knopf, H | 1 |
| Chen, J; Chronos, N; Geva, S; Jabara, R; Pendyala, L; Robinson, K | 1 |
| Abarca, B; Alemán, JJ; Baron-Esquivias, G; Egocheaga, I; Galve, E; Garcia-Moll, FX; González-Juanatey, JR; Lidón, RM; Llisterri, JL; Lobos, JM; Millán, J; Mostaza, JM; Pallares, V; Sánchez, PL; Suárez, C | 1 |
3 other study(ies) available for salicylic acid and cardiovascular agents
| Article | Year |
|---|---|
[Drug usage of men and women with coronary heart disease. Results of the German Federal Health Survey 1998].
Topics: Adolescent; Adult; Age Distribution; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiovascular Agents; Coronary Disease; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Female; Germany; Health Surveys; Humans; Male; Middle Aged; Population Surveillance; Prevalence; Risk Assessment; Risk Factors; Salicylic Acid; Sex Distribution; Socioeconomic Factors | 2004 |
Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Materials Testing; Models, Animal; Prosthesis Design; Salicylic Acid; Sirolimus; Sus scrofa; Time Factors; Tomography, Optical Coherence; Ultrasonography, Interventional | 2009 |
Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease.
Topics: Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Drug Combinations; Humans; Medication Adherence; Ramipril; Salicylic Acid; Secondary Prevention | 2017 |